The total return over the past 12 months is -45.19% vs. +16.94% for the S&P 500. So far it's up -31.88% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (45.19%) | (54.57%) | (50.73%) | N/A | N/A | N/A |
| Total Return CAGR | (45.19%) | (54.57%) | (50.73%) | N/A | N/A | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
ImageneBio Inc (IMA)
| Year | Start price | End price | IMA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $6.90 | $4.70 | (31.88%) | +14.51% | (46.39%) |
| 2025 | $19.68 | $6.90 | (64.94%) | +17.72% | (82.66%) |
| 2024 | $23.64 | $19.68 | (16.75%) | +24.89% | (41.64%) |
| 2023 | $31.92 | $23.64 | (25.94%) | +26.19% | (52.13%) |
| 2022 | $150.48 | $31.92 | (78.79%) | (18.17%) | (60.62%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
